HCPCS Level II code C1052 denotes a topical hemostatic agent for gastrointestinal use. These products are applied directly to bleeding sites in the GI tract during endoscopic or surgical procedures to achieve hemostasis. Nationally, use of topical gastrointestinal hemostats matters for procedural safety, device supply management, and procedure-level cost considerations across hospitals and ambulatory endoscopy centers.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for topical GI hemostats, typical sites of service, and the payer landscape addressed. The publication summarizes benchmark considerations for coverage and coding of C1052, highlights relevant clinical scenarios where topical hemostats are used, and outlines common documentation elements that payers review.

The content provides a practical reference for health system billing staff, revenue cycle leaders, and clinical procurement teams seeking clear definitions and payer scope. Data elements not provided in the input are noted as unavailable; the focus remains on accurate description of the code, clinical service setting, and the payers typically involved in adjudicating claims for topical gastrointestinal hemostatic agents.